Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Clinical Lipidology

• Publication date

  2011-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jacl.2011.03.453PMID 21600527
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Childhood Physical, Environmental, and Genetic Predictors of Adult Hypertension: The Cardiovascular Risk in Young Finns Study

  2012cited by this paper
• Lowering LDL-cholesterol through diet: potential role in the statin era

  2011cited by this paper
• Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia.

  2010cited by this paper
• Statins for children with familial hypercholesterolemia.

  2010cited by this paper
• Colesevelam

  2010cited by this paper
• Novel therapies and new targets of treatment for familial hypercholesterolemia.

  2010cited by this paper
• PCSK9: a convertase that coordinates LDL catabolism Published, JLR Papers in Press, November 19, 2008.

  2009cited by this paper
• Myopathy with statin–fibrate combination therapy: clinical considerations

  2009cited by this paper
• Ezetimibe as Monotherapy in the Treatment of Hypercholesterolemia in Children and Adolescents

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood: Evidence From the Childhood Determinants of Adult Health (CDAH) Study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study

  2008cited by this paper
• Lipid Screening and Cardiovascular Health in Childhood

  2008cited by this paper
• Recognition and management of dyslipidemia in children and adolescents.

  2008cited by this paper
• Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia.

  2008cited by this paper
• Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force

  2007cited by this paper
• Statin Treatment in Children With Familial Hypercholesterolemia: The Younger, the Better

  2007cited by this paper
• Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing.

  2007cited by this paper
• Statins and children: whom do we treat and when?

  2007cited by this paper
• Current status of cardiovascular gene therapy.

  2007cited by this paper
• Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

  2006cited by this paper
• LDL-apheresis therapy

  2006cited by this paper
• Pathobiological Determinants of Atherosclerosis in Youth Risk Scores Are Associated With Early and Advanced Atherosclerosis

  2006cited by this paper
• Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia

  2006cited by this paper
• Sensitivity and Specificity of Pediatric Lipid Determinations for Adult Lipid Status: Findings From the Princeton Lipid Research Clinics Prevalence Program Follow-up Study

  2006cited by this paper
• Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association.

  2005cited by this paper
• Efficacy and Safety of Lovastatin Therapy in Adolescent Girls With Heterozygous Familial Hypercholesterolemia

  2005cited by this paper
• Risk scores predict atherosclerotic lesions in young people.

  2005cited by this paper
• Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

  2004cited by this paper
• Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia.

  2004cited by this paper
• Lipid disorders and mutations in the APOB gene.

  2004cited by this paper
• Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

  2004cited by this paper
• Diagnostic, Clinical, and Therapeutic Aspects of Familial Hypercholesterolemia in Children

  2004cited by this paper
• Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

  2004cited by this paper
• Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study.

  2003cited by this paper
• Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial.

  2003cited by this paper
• Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study.

  2003cited by this paper
• Efficacy and Safety of Ezetimibe Coadministered With Atorvastatin or Simvastatin in Patients With Homozygous Familial Hypercholesterolemia

  2002cited by this paper
• Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Trial With Simvastatin

  2002cited by this paper
• Early statin therapy restores endothelial function in children with familial hypercholesterolemia.

  2002cited by this paper
• Vaccination against atherosclerosis: science or fiction?

  2002cited by this paper
• Distribution and correlates of non-high-density lipoprotein cholesterol in children: the Bogalusa Heart Study.

  2002cited by this paper
• A Randomized Crossover Trial of Combination Pharmacologic Therapy in Children with Familial Hyperlipidemia

  2002cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Effects of Nonlipid Risk Factors on Atherosclerosis in Youth With a Favorable Lipoprotein Profile

  2001cited by this paper
• Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

  2000cited by this paper
• Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth.

  2000cited by this paper
• Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group.

  1999cited by this paper
• Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial.

  1999cited by this paper
• Cholesterol in Childhood

  1998cited by this paper
• Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey.

  1998cited by this paper
• Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.

  1998cited by this paper
• Determinants of atherosclerosis in the young

  1998cited by this paper
• Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial.

  1997cited by this paper
• Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth.

  1997cited by this paper
• The relation of apolipoprotein E polymorphism to multiple cardiovascular risk in children: the Bogalusa Heart Study.

  1996cited by this paper
• Short-Term Efficacy and Safety of Pravastatin in 72 Children with Familial Hypercholesterolemia

  1996cited by this paper
• Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia.

  1996cited by this paper
• Usefulness of childhood low-density lipoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks. The Bogalusa Heart Study.

  1996cited by this paper
• Failure of current guidelines for cholesterol screening in urban African-American adolescents.

  1996cited by this paper
• Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.

  1996cited by this paper
• A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

  1995cited by this paper
• Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents.

  1995cited by this paper
• A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

  1995cited by this paper
• Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: the Bogalusa Heart Study.

  1995cited by this paper
• Challenges to implementing the current pediatric cholesterol screening guidelines into practice.

  1994cited by this paper
• Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12-year follow-up. The Cardiovascular Risk in Young Finns study.

  1994cited by this paper
• Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics.

  1993cited by this paper
• Niacin treatment of hypercholesterolemia in children.

  1993cited by this paper
• National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.

  1992cited by this paper
• Simvastatin use in children.

  1992cited by this paper
• Cholesterol screening in childhood: sixteen-year Beaver County Lipid Study experience.

  1991cited by this paper
• Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.

  1991cited by this paper
• Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study.

  1991cited by this paper
• The Bogalusa Heart Study

  1991cited by this paper
• Cholesterol screening in childhood: Sixteen-year Beaver Coynty Lipid Study experience

  1991cited by this paper
• First-pass metabolism of cyclosporin by the gut.

  1991cited by this paper
• Family History Evaluation as a Predictive Screen for Childhood Hypercholesterolemia

  1989cited by this paper
• Cardiovascular risk factors from birth to 7 years of age: the Bogalusa Heart Study. Serum lipids and lipoproteins.

  1987cited by this paper
• Patterns of dyslipoproteinemia in selected North American populations. The Lipid Research Clinics Program Prevalence Study.

  1986cited by this paper
• Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa heart study

  1986cited by this paper
• Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study.

  1986cited by this paper
• Double blind trial of bezafibrate in familial hypercholesterolaemia.

  1985cited by this paper
• Lipid and lipoprotein distributions in white children ages 6-19 yr. The Lipid Research Clinics Program Prevalence Study.

  1981cited by this paper
• Neonatal diagnosis of familial type II hyperlipoproteinemia.

  1976cited by this paper
• Neonatal diagnosis of familial type-II hyperlipoproteinaemia.

  1973cited by this paper
• Committee on Nutrition

  1956cited by this paper

• Serum Syndecan-1 is Associated With Kidney and Cardiovascular Outcomes in Idiopathic Nephrotic Syndrome

  2025cites this paper
• Efficacy of PCSK9 inhibitors on pediatric patients with heterozygous familial hypercholesterolemia: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Familial hypercholesterolaemia in Greek females. An epidemiological study

  2025cites this paper
• Significance of Diet Therapy in the Development and Treatment of Cardiovascular Diseases

  2025cites this paper
• Clinical Management of Dyslipidemia in Infants and Toddlers

  2025cites this paper
• Familial Hypercholesterolemia Screening in Childhood and Early Adulthood: A Cost-Effectiveness Study.

  2025cites this paper
• “I don’t think people should die young”: perspectives of parents with children diagnosed with familial hypercholesterolemia

  2024cites this paper
• The Role of Reverse Cascade Screening in Children with Familial Hypercholesterolemia: A Literature Review and Analysis

  2024cites this paper
• Genetic testing for familial hypercholesterolemia

  2024cites this paper
• Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol.

  2024cites this paper
• Longitudinal analysis of blood pressure and lipids in childhood nephrotic syndrome

  2024cites this paper
• It is Time to Screen for Homozygous Familial Hypercholesterolemia in the United States

  2024cites this paper
• Using implementation science to develop a familial hypercholesterolemia screening program in primary care: The CARE-FH study.

  2024cites this paper
• 2024 Polish recommendations for the management of familial hypercholesterolemia in children and adolescents

  2024cites this paper
• The effectiveness of liver transplantation in reducing lipid levels in Saudi children with homozygous familial hypercholesterolemia

  2024cites this paper
• Myopathy in Statin-Treated Children and Adolescents: A Practical Approach

  2024cites this paper
• ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins.

  2024cites this paper
• Familial hypercholesterolemia and cascade screening for detection of new patients

  2023cites this paper
• Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study.

  2023cites this paper
• Labordiagnostik von Fettstoffwechselstörungen

  2023cites this paper
• Cholesterol screening and intervention in youth - It's time to move on.

  2023cites this paper
• Algorithms for Treating Dyslipidemia in Youth

  2023cites this paper
• Evidence and Uncertainties on Lipoprotein(a) as a Marker of Cardiovascular Health Risk in Children and Adolescents

  2023cites this paper
• Hyperlipidemia and Cardiovascular Risk in Children and Adolescents

  2023cites this paper
• A Selective Screening Strategy Performed in Pre-School Children and Siblings to Detect Familial Hypercholesterolemia

  2022cites this paper
• Pediatric dyslipidemia

  2022cites this paper
• Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia: a cross-sectional study

  2022cites this paper
• Perioperative Management and Clinical Outcomes of Liver Transplantation for Children with Homozygous Familial Hypercholesterolemia

  2022cites this paper
• Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: design of the VRONI study

  2022cites this paper
• Familial hypercholesterolaemia in children and adolescents: current and future perspective.

  2022cites this paper
• Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinician

  2022cites this paper
• Familial hypercholesterolemia – treatment update in children, systematic review

  2022influential citation
• Identification of New Genetic Determinants in Pediatric Patients with Familial Hypercholesterolemia Using a Custom NGS Panel

  2022cites this paper
• Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases

  2022cites this paper
• Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: design of the VRONI study

  2021cites this paper
• Prevention starts from the crib: the pediatric point of view on detection of families at high cardiovascular risk

  2021cites this paper
• Long term follow-up of children with familial hypercholesterolemia and relatively normal LDL-cholesterol at diagnosis.

  2021cites this paper
• Rhabdomyolysis due to rosuvastatin in a patient with ROHHAD syndrome.

  2021cites this paper
• Lipid Disorders in Children and Adolescents

  2021cites this paper
• Evolocumab in the management of children <10 years of age affected by homozygous familial hypercholesterolemia.

  2021cites this paper
• Efficacy of therapeutic lifestyle changes on lipid profiles assessed by NMR in children with familial and non-familial hypercholesterolemia.

  2020cites this paper
• Familial Hypercholesterolemia: Improving Outcomes with Newer Agents

  2020cites this paper
• Case Report: Liver Transplantation in Homozygous Familial Hypercholesterolemia (HoFH)—Long-Term Follow-Up of a Patient and Literature Review

  2020cites this paper
• Cascade screening and treatment of children with familial hypercholesterolemia in Turkey

  2020cites this paper
• Effectiveness and Safety of Statin Therapy in Children: A Real-World Clinical Practice Experience

  2020cites this paper
• Intermediate-Term Efficacy and Tolerance of Statins in Children.

  2019cites this paper
• Diagnosis and management of children and young people with familial hypercholesterolaemia

  2019cites this paper
• Selective screening for familial hypercholesterolemia in Austrian children - first year results

  2019cites this paper
• Improving Long-term Outcomes of Youth with Lipid Abnormalities- Expanding the Role of Pediatric Endocrinologists.

  2019cites this paper
• Dislipemias en la edad pediátrica. Importancia del diagnóstico y tratamiento precoces

  2019cites this paper
• Coenzyme Q10 deficiency in familial hypercholesterolemia

  2019cites this paper
• Can Non-Pharmacological Treatment Promote Additional Benefit for Children with Familial Hypercholesterolemia Treated with Statins?

  2018cites this paper
• Parent–child genetic testing for familial hypercholesterolaemia in an Australian context

  2018cites this paper
• Cholesterol screening and statin use in children: a literature review

  2018influential citation
• The complex molecular genetics of familial hypercholesterolaemia

  2018cites this paper
• Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.

  2018cites this paper
• Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT study.

  2018cites this paper
• Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis

  2018cites this paper
• Screening, Diagnosis, and Treatment of Familial Hypercholesterolemia: Symposium of the Education Committee, Korean Society of Lipid and Atherosclerosis

  2018cites this paper
• Circulating miR-200c is up-regulated in paediatric patients with familial hypercholesterolaemia and correlates with miR-33a/b levels: implication of a ZEB1-dependent mechanism.

  2017cites this paper
• Temporal trends in lipid testing among children and adolescents: A population based study

  2017influential citation
• Treatment of Heterozygous Familial Hypercholesterolemia in Children and Adolescents: An Unsolved Problem.

  2017cites this paper
• Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies

  2017cites this paper
• Familial hypercholesterolemia in childhood and adolescents: A hidden reality.

  2017cites this paper
• Familial hypercholesterolaemia

  2017cites this paper
• Familial hypercholesterolemia in childhood and adolescents: A hidden reality.

  2017cites this paper
• Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.

  2017cites this paper
• Knowns and unknowns in the care of pediatric familial hypercholesterolemia

  2017cites this paper
• Prevalence of high cholesterol levels suggestive of familial hypercholesterolemia in Brazilian adolescents: Data from the study of cardiovascular risk in adolescents.

  2017cites this paper
• Tratamiento de la hipercolesterolemia familiar heterocigota en la infancia y la adolescencia: un problema no resuelto

  2017cites this paper
• Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians

  2017cites this paper
• Efficacy and Safety of Pitavastatin in Children and Adolescents with Familial Hypercholesterolemia in Japan and Europe

  2017cites this paper
• Consecución de objetivos terapéuticos de colesterol LDL en niños y adolescentes con hipercolesterolemia familiar. Registro longitudinal SAFEHEART

  2017cites this paper
• Optimising strategies for the detection of familial hypercholesterolaemia

  2016cites this paper
• Screening for genetic mutations in children and adolescents with dyslipidemia: importance of early identification and implications of missed diagnoses

  2016cites this paper
• International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next?

  2016cites this paper
• Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia.

  2016cites this paper
• Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force

  2016influential citation
• Hipercolesterolemia familiar: artículo de revisión

  2016cites this paper
• High density lipoprotein subfractions and paraoxonase 1 in children.

  2016cites this paper
• Familial Hypercholesterolemia.

  2016cites this paper
• A 10-year experience using combined lipid-lowering pharmacotherapy in children and adolescents

  2016cites this paper
• Statins in the Management of Pediatric Dyslipidemia.

  2016cites this paper
• Distribution and correlates of non-high-density lipoprotein cholesterol and triglycerides in Lebanese school children.

  2016cites this paper
• An 8-Year-Old Boy Presenting with Eruptive, Pruritic Rash and Cough.

  2016cites this paper
• Familial hypercholesterolemia in children

  2016cites this paper
• Familial Hypercholesterolemia: Advances in Recognition and Therapy.

  2016cites this paper
• Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2016cites this paper
• FAMILIAL HYPERCHOLESTEROLEMIA IN TEHRAN LIPID AND GLUCOSE STUDY: A CROSS- SECTIONAL STUDY

  2016cites this paper
• Treatment decision making for adolescents with familial hypercholesterolemia: Role of family history and past experiences.

  2015cites this paper
• [Familial Hypercholesterolemia].

  2015cites this paper
• National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.

  2015cites this paper
• Hot Topics in Primary Care: Familial Hypercholesterolemia in Youth.

  2015cites this paper
• Screening for Familial Hypercholesterolaemia: Universal or Cascade? A Critique of Current FH Recognition Strategies

  2015cites this paper
• Pediatric guidelines for dyslipidemia.

  2015cites this paper
• Efficacy and safety of ezetimibe monotherapy in children with heterozygous familial or nonfamilial hypercholesterolemia.

  2015cites this paper
• Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

  2015cites this paper
• Temporal trends in lipid screening and therapy among youth from 2002 to 2012.

  2015cites this paper
• Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.

  2015cites this paper
• Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

  2015influential citation